Physician profile
Paul Knapp
NPI 1528410099
$12,114.65
in general payments reported to CMS, 2019-2025
10 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,208 · 2020: $282 · 2021: $2,861 · 2022: $2,337 · 2023: $573 · 2024: $2,253 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,472 · Travel and Lodging: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,471.63 |
| Travel and Lodging | $955.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,781.34 | 2019-2025 | Mako, Insignia, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $3,045.02 | 2019-2022 | |
| Pinnacle, INC | $1,211.07 | 2021 | |
| Smith+Nephew, INC. | $493.14 | 2022-2025 | Real Intelligence, Journey II, Redapt |
| Depuy Synthes Sales INC. | $292.45 | 2019-2024 | Na, Expert Nail, Tfn-Advance |
| Davol INC. | $133.07 | 2022 | |
| Paragon 28, INC. | $79.53 | 2019 | |
| Acera Surgical, INC. | $29.56 | 2025 | Restrata Wound Matrix |
| Medical Device Business Services, INC. | $28.09 | 2021 | |
| Medtronic, INC. | $21.38 | 2024 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Knapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.